Virology

WHO assessment of experimental Ebola virus vaccines

The World Health Organization held a conference to assess the status of testing and eventual licensing of two candidate Ebola virus vaccines. The agenda and list of participants and the final report are available. I was interested in the following list of key expected milestones: October 2014: Mechanisms for evaluating and sharing data ...

Would we have an Ebola virus vaccine if not for NIH cuts?

Dr. Francis Collins, the head of the National Institutes of Health, believes that we would have an Ebola virus vaccine if not for the past ten years of flat budgets for life science research: NIH has been working on Ebola vaccines since 2001. It's not like we suddenly woke up ...

Enterovirus D68 infections in North America

Enterovirus D68 by Jason Roberts An outbreak of respiratory disease caused by enterovirus D68 began in August of this year with clusters of cases in Missouri and Illinois. Since then 691 infections have been confirmed in 46 states in the US. The number of confirmed infections is likely to increase in the ...

Combination antiviral therapy for hepatitis C

The Food and Drug Administration has approved the use of a single pill containing two different antiviral drugs for the treatment for hepatitis C. It is the first combination pill approved for the disease, and also the first treatment that does not contain interferon or ribavirin. The new hepatitis C drug, ...

New Yorkers like their science from scientists

I cannot pass up the opportunity to point out this wonderful quote by Ginia Ballafante in her NY Times piece, Fear of Vaccines Goes Viral. The article starts by noting an article on plummeting vaccination rates in Los Angeles: The piece had the virtue of offering New Yorkers yet another opportunity ...
Scroll to Top